The reason is called a “doctor’s order” rather than a “doctor’s suggestion.”
“Real Housewife in New Jersey” star Jennifer Fesler After she “ignoring” the doctor’s advice, she learned the difficult methods when she suffered from painful side effects from GLP-1 weight loss medication.
“I did everything wrong,” said Festler, 55, who recalled how the brutal match of constipation landed her in the hospital with her shocked gut, and the sheer amount of regret.
Drug Fessler was taking when he was suffering from painful side effects, semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist sold under the brand names Ozenpic, Wegoby and Libers.
Originally approved for treatment for type 2 diabetes, this injectable drug therapy has become a popular weight loss solution that will help users to fulfill their users for longer.
In 2023, nearly 5 million Americans were prescribed semaglutide, with nearly 40% using it for weight management. Epic poetry research Share with CNN only.
Fessler’s reality check
Fessler was not looking for the GLP-1.
The reality TV star began working with hormone experts after struggling with severe hot flashes during the perimenopause period.
“I was on this TV show and filming. Suddenly, I was sweating. It was very frustrating, not to mention the fact that my whole body really hurts,” Fessler said.
She also admitted to “adding a lot of weight” during the menopause transition, but noted that her battle with Scale was lifelong.
“Food and weight have always bothered me,” Fessler said. Losing the pound was never easy, but “change” became even more difficult for her.
Then came the semaglutide – and everything changed.
“Of course, the aesthetics of it is amazing. I love how it gets thinner and fits the clothes I want to wear.
Jennifer Fesler
Fessler said that he had “a tremendous success” with injectable drug therapy, but that the pain of her hunger had disappeared and she felt faster.
Suddenly, she was not consumed by the idea of food and weight, and shed about 20 pounds in the process.
“Of course, the aesthetic is amazing. I love how it gets thinner and fits the clothes I want to wear,” Fessler said.
“But the biggest advantage for me is the drop in volume in every voice in my head about the food and my body. They all got really quiet.
But of course, it wasn’t all smooth sailing.
“Before I started taking the medication, my doctor told me to drink lots of water, eat vegetables, and take cologne and mirarax,” explained Fessler.
“I ignored it all,” she confessed.
It didn’t take long for Fessler to begin experiencing constipation. She initially brushed it off, but nearly two weeks after not passing through the stool, she checked herself in the hospital with the shocked gut.
“I don’t recommend it,” she said. “It wasn’t a fun experience, but I knew I hadn’t followed the instructions.”
Currently, Fessler, who is still taking GLP-1 medications, stays on top of drinking water, eats plenty of fibre vegetables and regularly consumes Mirarax.
“I’ve never had any problems since. It’s now back two years ago,” she said.
Semaglutide and your intestines
Side effects such as constipation, diarrhea, nausea, and abdominal pain are common in semaglutide, but the effects of drugs on the intestines are continuing to be studied.
One way Semaglutide works is to slow down the stomach content. This is the speed at which food moves through the stomach and intestines. This slow process allows food to stay longer in the stomach and may absorb more water in the colon.
result? Hard and dry stool that is difficult to pass through.
When stool accumulates in your colon, obstruction can occur, leading to constipation and, in serious cases, shocked intestines. This can cause severe stomach pain, bloating, nausea, loss of appetite and fatigue.
Since they were on the market, the FDA has updated the labels for Ozempic, Wegovi and Libers to warn them of the risk of “severe gastrointestinal side effects.”
It includes Chance to develop Ileus – A life-threatening condition in which the intestines can stop the movement of food and waste, limit blood flow to organs, and lead to blockages that can lead to tissue death.
The agent has received it 239 Report of Ileus As of December 31, 2024, patients taking semaglutide, including five deaths.
This drug is also associated with severe gastroparesis, a rare condition that affects spontaneous movement of the stomach muscles and can slow the movement of the intestines.
